SEC Form 4 · accession 0001628280-26-045501
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carolyn S Starrett
Director
Period of report
Jun 23, 2026
Accepted (ET)
Jun 25, 2026 · 4:09 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001077183
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $11.20 | Jun 23, 2026 | A | 9,784 | A | Jun 1, 2027 | Jun 1, 2036 | Common Stock | 9,784 | 9,784 | D |
| Restricted Stock UnitF1 | $0.00 | Jun 23, 2026 | A | 14,125 | A | Jun 1, 2027 | — | Common Stock | 14,125 | 14,125 | D |
Explanation of responses
- F1Once vested, the shares of common stock are not subject to expiration.